XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $343,958 | -11.3% | 10,069 | 0.0% | 0.17% | -8.3% |
Q2 2023 | $387,657 | -27.8% | 10,069 | -32.8% | 0.18% | -28.7% |
Q1 2023 | $536,636 | -9.2% | 14,994 | 0.0% | 0.25% | -13.9% |
Q4 2022 | $591,213 | +9.3% | 14,994 | 0.0% | 0.30% | +9.3% |
Q3 2022 | $541,000 | +18.6% | 14,994 | 0.0% | 0.27% | +4.2% |
Q2 2022 | $456,000 | -0.4% | 14,994 | 0.0% | 0.26% | +10.2% |
Q1 2022 | $458,000 | -18.9% | 14,994 | -17.1% | 0.24% | -12.6% |
Q4 2021 | $565,000 | +61.9% | 18,080 | -3.5% | 0.27% | +46.2% |
Q2 2021 | $349,000 | +4.2% | 18,729 | 0.0% | 0.18% | -9.8% |
Q1 2021 | $335,000 | +42.6% | 18,729 | 0.0% | 0.20% | +6.8% |
Q3 2020 | $235,000 | 0.0% | 18,729 | 0.0% | 0.19% | 0.0% |
Q2 2020 | $235,000 | -99.7% | 18,729 | 0.0% | 0.19% | +117.0% |
Q1 2020 | $91,772,000 | +37205.7% | 18,729 | 0.0% | 0.09% | -58.9% |
Q4 2019 | $246,000 | +45.6% | 18,729 | 0.0% | 0.21% | +25.1% |
Q3 2019 | $169,000 | -8.6% | 18,729 | 0.0% | 0.17% | +4.3% |
Q2 2019 | $185,000 | -2.6% | 18,729 | 0.0% | 0.16% | -6.8% |
Q1 2019 | $190,000 | +61.0% | 18,729 | 0.0% | 0.18% | +54.4% |
Q4 2018 | $118,000 | -100.0% | 18,729 | 0.0% | 0.11% | -44.4% |
Q3 2018 | $247,223,000 | -6.4% | 18,729 | -50.0% | 0.20% | -14.6% |
Q2 2018 | $264,078,000 | +187.8% | 37,458 | +100.0% | 0.24% | +172.7% |
Q1 2018 | $91,772,000 | – | 18,729 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |